Granahan Investment Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-347,529
| Closed | -$3.77M | – | 198 |
|
|
2024
Q2 | $3.77M | Buy |
347,529
+191,158
| +122% | +$2.08M | 0.15% | 141 |
|
|
2024
Q1 | $2.93M | Buy |
+156,371
| New | +$2.93M | 0.1% | 149 |
|
|
2016
Q4 | – | Sell |
-316,065
| Closed | -$14.6M | – | 242 |
|
|
2016
Q3 | $14.6M | Sell |
316,065
-163,210
| -34% | -$7.52M | 0.48% | 90 |
|
|
2016
Q2 | $14.4M | Sell |
479,275
-7,710
| -2% | -$232K | 0.53% | 76 |
|
|
2016
Q1 | $15.6M | Buy |
486,985
+212,100
| +77% | +$6.8M | 0.57% | 63 |
|
|
2015
Q4 | $16M | Sell |
274,885
-36,380
| -12% | -$2.12M | 0.55% | 66 |
|
|
2015
Q3 | $13.2M | Buy |
311,265
+36,600
| +13% | +$1.55M | 0.41% | 88 |
|
|
2015
Q2 | $20.1M | Buy |
274,665
+125,509
| +84% | +$9.16M | 0.57% | 64 |
|
|
2015
Q1 | $7.49M | Buy |
+149,156
| New | +$7.49M | 0.21% | 151 |
|